
|Videos|March 22, 2022
PharmExec CEO Roundtable: Post-COVID Improvements
In this segment, leaders suggest areas to continue building on lessons learned during COVID, including the pharma industry as a tech destination and impact on patient outcomes.
Advertisement
Please read the
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026 Preview: What Path Will Pfizer Take?
2
FDA Approves Nereus for the Prevention of Motion Induced Vomiting
3
JP Morgan 2026 Preview: Merck Prepares for the Patent Cliff
4
JP Morgan 2026 Preview: Johnson & Johnson Prepares a Fireside Chat
5




